Cheryl Lancto
About Cheryl Lancto
Cheryl Lancto serves as the Director of Laboratory Operations at Recombinetics, where she oversees purchasing, inventory, and project budget tracking. With a background in microbiology and extensive experience in cell biology and molecular fields, she plays a significant role in advancing gene editing technologies and ensuring ethical standards in animal research.
Work at Recombinetics
Cheryl Lancto currently serves as the Director of Laboratory Operations at Recombinetics, Inc., a position she has held since 2016. In this role, she manages various aspects of laboratory operations, including purchasing, inventory management, and project budget tracking. Her responsibilities also extend to the acquisition of intellectual property related to gene editing technologies, ensuring that the company remains at the forefront of advancements in this field. Additionally, she plays a significant role in the commercialization of gene-edited animals and tissues, aligning with the company's strategic vision.
Education and Expertise
Cheryl Lancto earned her Bachelor of Science degree in Microbiology from Montana State University - Bozeman. She furthered her education at the University of Minnesota, where she completed a Master's degree in Biological Science, focusing on Biology and Immunology. Her academic background provides a strong foundation for her technical proficiency in cell biology and molecular fields, which she applies in her current role to advance animal health and agricultural livestock genome engineering.
Background
Before her current position, Cheryl Lancto worked as a Senior Scientist at Recombinetics, Inc. from 2012 to 2016. Prior to that, she spent 18 years at the University of Minnesota in a similar role from 1994 to 2012. This extensive experience in scientific research and laboratory management has equipped her with the skills necessary to lead operations effectively in her current role.
Achievements
Cheryl Lancto chairs the Institutional Animal Care and Use Committee (IACUC) at Recombinetics, where she ensures compliance with ethical standards in animal research. Her leadership in this committee underscores her commitment to ethical practices in scientific research. Through her work, she contributes to the responsible advancement of gene editing technologies in the agricultural sector.